HBW
IOVA icon

Hazlett, Burt & Watson’s Iovance Biotherapeutics IOVA Stock Holding History

Hazlett, Burt & Watson’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
100
– – ﹤0.01% 936
2025
Q4 		$0 Hold
100
– – ﹤0.01% 937
2025
Q3 		$0 Hold
100
– – ﹤0.01% 896
2025
Q2 		$0 Hold
100
– – ﹤0.01% 827
2025
Q1 		$0 Hold
100
– – ﹤0.01% 816
2024
Q4 		$1K Hold
100
– – ﹤0.01% 731
2024
Q3 		$1K Hold
100
– – ﹤0.01% 702
2024
Q2 		$1K Hold
100
– – ﹤0.01% 679
2024
Q1 		$1K Hold
100
– – ﹤0.01% 679
2023
Q4 		$1K Sell
100
-47
-32% -$246 ﹤0.01% 654
2023
Q3 		$0 Hold
147
– – ﹤0.01% 729
2023
Q2 		$1K Hold
147
– – ﹤0.01% 646
2023
Q1 		$1K Hold
147
– – ﹤0.01% 593
2022
Q4 		$1K Hold
147
– – ﹤0.01% 593
2022
Q3 		$1K Hold
147
– – ﹤0.01% 597
2022
Q2 		$2K Buy
147
+47
+47% +$616 ﹤0.01% 561
2022
Q1 		$2K Buy
+100
New +$1.55K ﹤0.01% 561

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return